• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1.

作者信息

Suzuki H, Takahashi K, Shibahara S

机构信息

Department of Applied Physiology and Molecular Biology, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Tohoku J Exp Med. 1995 Apr;175(4):225-33. doi: 10.1620/tjem.175.225.

DOI:10.1620/tjem.175.225
PMID:7570581
Abstract

Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder, primarily affecting cells of neural crest origin, and is characterized by café-au-lait skin spots, multiple neurofibromas, and higher incidence of malignancy. A gene linked to NF1 encodes neurofibromin, an established function of which is to stimulate intrinsic GTPase activity of ras protein. The neurofibromin gene gives rise to multiple transcripts generated by alternative splicing, that encode various neurofibromin isoforms. In this study, we have cloned a cDNA encoding a newly identified species of a putative amino-terminal isoform which lacks a large portion of neurofibromin, including the domain related to GTPase-activating protein. This clone carries the insert of 2.7 kb, coding for a protein of 593 amino acid residues, tentatively termed N-isoform 11, whose amino-terminal 574 residues are identical to those of authentic neurofibromin encoded by the eleven exons located at the 5' portion of the gene. Previously, we cloned a cDNA coding for a similar isoform of 551 amino acid residues, termed N-isoform 10, whose amino-terminal portion is encoded by the first ten exons. The molecular weights of these two deduced N-isoforms are consistent with the values determined by in vitro translation of the mRNA transcribed from each N-isoform cDNA. The presence of the amino-terminal isoform(s) suggests the physiological significance of the amino-terminal portion of neurofibromin.

摘要

相似文献

1
Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1.
Tohoku J Exp Med. 1995 Apr;175(4):225-33. doi: 10.1620/tjem.175.225.
2
Multiple transcripts of the neurofibromatosis type 1 gene in human brain and in brain tumours.人类大脑及脑肿瘤中1型神经纤维瘤病基因的多种转录本
Clin Sci (Lond). 1994 Nov;87(5):481-5. doi: 10.1042/cs0870481.
3
Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating protein.
Biochem Biophys Res Commun. 1992 Sep 16;187(2):984-90. doi: 10.1016/0006-291x(92)91294-z.
4
Activation of the tyrosinase gene promoter by neurofibromin.神经纤维瘤蛋白对酪氨酸酶基因启动子的激活作用。
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1984-91. doi: 10.1006/bbrc.1994.2903.
5
Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.1型神经纤维瘤病中神经纤维瘤蛋白GAP活性的选择性失活
Hum Mol Genet. 1998 Aug;7(8):1261-8. doi: 10.1093/hmg/7.8.1261.
6
Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues.
Dev Dyn. 1995 Mar;202(3):302-11. doi: 10.1002/aja.1002020309.
7
[Genetics of type 1 neurofibromatosis].[1型神经纤维瘤病的遗传学]
Acta Biomed Ateneo Parmense. 2000;71(3-4):89-95.
8
Analysis of the sequence and embryonic expression of chicken neurofibromin mRNA.鸡神经纤维瘤蛋白mRNA的序列及胚胎表达分析。
Mol Chem Neuropathol. 1993 Apr;18(3):267-78. doi: 10.1007/BF03160119.
9
Molecular genetics of neurofibromatosis type 1 (NF1).1型神经纤维瘤病(NF1)的分子遗传学
J Med Genet. 1996 Jan;33(1):2-17. doi: 10.1136/jmg.33.1.2.
10
Reduced expression of neurofibromin in the soft tissue tumours obtained from patients with neurofibromatosis type I.
Clin Sci (Lond). 1995 May;88(5):581-5. doi: 10.1042/cs0880581.